NIH-funded research R15 grant

How bacterial communication affects their growth and survival

Official title: Peptide cues in the environment regulate bacterial dormancy

Funded at Salve Regina University · NIH-10874289 · Data updated 2026-11-12

This study looks at how E. coli bacteria talk to each other using tiny signals in their surroundings, which helps them decide when to rest or stay active, and it also gives students a chance to learn about this fascinating process.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionSalve Regina University
NIH-funded
Lab location1 site (Newport, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2027
Funding year2024
Award (this year)$387,866
NIH project number1R15GM154245-01
Project IDNIH-10874289 on NIH RePORTER

Who could benefit from this research

Could help

Patients with infections caused by antibiotic-resistant bacteria may benefit from the findings of this research.

Less likely to help

Patients with non-bacterial infections or those not affected by antibiotic resistance may not receive any benefit from this research.

What this research studies

This research investigates how bacteria communicate through molecular cues in their environment, particularly focusing on how these signals influence bacterial dormancy and survival. By studying a specific strain of E. coli, the project aims to identify the molecules involved in this communication and the genetic responses they trigger. The research employs a combination of synthetic chemistry, bacterial genetics, and proteomics to uncover the mechanisms of bacterial crosstalk. This work also includes training undergraduate students in relevant scientific disciplines, enhancing their educational experience.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for combating antibiotic resistance in pathogenic bacteria.

How similar studies have gone: Previous research has shown that understanding bacterial communication can lead to breakthroughs in treating infections, suggesting that this approach has potential for success.

Where this research is happening

  • Salve Regina University
    Newport, United States
    Active

Researchers

  • Principal investigator: Meschwitz, Susan — Salve Regina University
  • Study coordinator: Meschwitz, Susan

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.